Prosensa price target raised to $11 from $8 at Leerink
4 minutes ago
Leerink raised its price target on Prosensa to $11 from $8, saying it expects the company will meet with the FDA regarding the next steps for drisapersen during the first half of the year. Leerink maintains an Outperform rating on Prosensa.
All in all...a much more encouraging close than it initially appeared to be. Wish it would have held $7.00. Oh well, tomorrow's another day. This should trade upwards tomorrow for further confirmation of move. GLTA.